期刊文献+

单独使用瑞芬太尼用于经皮肝癌射频消融手术的麻醉 被引量:4

Remifentanil as a Single Agent to Provide Analgosedation for Percutaneous Radiofrequency Ablation of Hepatic Cancer.
下载PDF
导出
摘要 目的 探讨单独使用瑞芬太尼为经皮肝癌射频消融手术提供镇静镇痛麻醉的可行性和安全性.方法 选取30例ASA Ⅰ~Ⅲ级拟行经皮肝癌射频消融术的患者.所有患者均未给予术前用药.手术开始前,首先给予瑞芬太尼0.1μg/(kg·min)持续输注,然后以0.01μg/(kg· min)的增减量调整输注速率,直到患者的镇静评分(OAA/S评分法)达到3分左右时开始手术.术中监测患者的血压、心率、血氧饱和度、呼吸频率.同时观察患者的体动、呼吸抑制等任何不良反应.术后随访患者的满意程度和术中知晓情况.结果 所有患者均顺利完成手术.术中血流动力学稳定,无明显不良反应发生.瑞芬太尼的平均输注速率为0.15 ±0.01μg/(kg·min),使用总量为6.63±1.51μg/kg.手术结束停药后,患者的意识恢复时间为11±2min.尽管部分患者呼吸频率出现明显降低,但血氧饱和度均维持在90%以上.结论 单独使用瑞芬太尼可以安全有效的用于经皮肝癌射频消融术的镇静麻醉,其产生的轻度呼吸抑制作用并无临床意义,但部分患者对手术过程的记忆仍需值得注意. Objective To investigate the feasibility and safety of remifentanil as a single agent providing analgosedation for percutaneous radiofrequency ablation of hepatic caner.Methods Thirty patients,ASA Ⅰ-Ⅲ,scheduled for percutaneous radiofrequency ablation of hepatic caner were enrolled in the study.No patients received premedication.All patients received continuous infusion of remifentanil at an initial dose of 0.1μg/(kg · min),which was titrated by an increment or decrement of 0.01 μg/(kg · min) to achieve OAA/S score of 3 (2-4).Blood pressure,heart rate,blood oxygen saturation and respiratory frequency were monitored.Also,the adverse events such as dyspnea,body movement were noted.Results The procedure was successfully finished in all patients without any severe adverse events.To obtain the adequate sedation state,the average infusing rate of remifentanil was 0.15 ± 0.01 μg/(kg · min).The total consumption of remifentanil was 6.63 ± 1.51μg/kg.The recovery time from sedation state to fully awake was 11 ± 2min.The blood oxygen saturation was maintained above 90%,although a significant decrease in respiratory frequency occurred in some cases.Conclusion Analgosedation with remifentanil as a single agent is a feasible and safe technique for percutaneous radiofrequency ablation of hepatic caner without any severe adverse effects.The associated slight respiratory depression is clinically insignificant.The recall of intraoperative events might be a relative concern.
作者 张国华 孙莉
出处 《医学研究杂志》 2013年第9期100-102,共3页 Journal of Medical Research
关键词 肝癌 射频消融术 瑞芬太尼 镇静镇痛麻醉 Hepatic cancer Radiofrequency ablation Remifentanil Analgosedation
  • 相关文献

参考文献10

  • 1Glass PS, Gan TJ, Howell S, et al. A review of the pharmacokinetics and pharmacodynamies of remifentanil [ J 1 - Anesth Analg, 1999, 89 (4) : 7 -14.
  • 2李毅,黄婉,龙浴辉,李伟,王剑,陈敏山,许梅曦.瑞芬太尼复合异丙酚静脉麻醉在肝癌射频消融术中的应用[J].癌症,2007,26(3):322-324. 被引量:15
  • 3高恒军,陈敏山.原发性肝癌的射频消融治疗[J].临床肝胆病杂志,2012,28(4):249-252. 被引量:13
  • 4Toklu S, Iyilikei L, Gonen C, et al. Comparison of tomidate - remifentanil and propofol - remifentanil sedation in patients scheduled for colonoscopy [ J ]. Eur J Anaesthesiol, 2009,26 ( 5 ) :370 - 376.
  • 5Burlaeu CL, McKeating K, MeShane AJ. Remifentanil for the inser- tion and removal of long - term central venous access during monitored anesthesia eare[J]. J Clin Anesth, 2011,23(4) :286 -291.
  • 6Smith I, Avramov MN, White PF. A comparison of propofol and remifentanil during monitored anesthesia care [ J ]. J Clin Anesth, 1997,9(2) :148 - 154.
  • 7Vennila R, Hall A, Ali M, et al. Remifentanil as single agent to fa- cilitate awake fibreoptie intubation in the absence of premedication [J]. Anaesthesia, 2011,66(5):368-372.
  • 8Atkins JH, Mandel JE, Mirza N. Laser Ablation of a large tongue he- mangioma with remifentanil analgosedation in the ORL endoscopy suite [ J]. ORL J Otorhinolaryngol Relat Spec, 2011,73 ( 3 ) : 166 - 169.
  • 9Lee MC, Absalom AR, Menon DK, et al. Awake insertion of the la- ryngeal mask airway using topical lidocaine and intravenous remifen- tanil[J]. Anaesthesia, 2006,61 (1) :32 - 35.
  • 10Olofsen E, Boom M, Nieuwenhuijs D, et al. Modeling the non - steady state respiratory effects of remifentanil ill awake and propofol - sedated healthy volunteers [ J ]. Anesthesiology, 2010,112 (6) : 1382 - 1395.

二级参考文献30

  • 1梁惠宏,陈敏山,王旭东,张亚奇,郑云,李锦清.经皮射频消融治疗不同类型肝癌的疗效分析[J].中华肝脏病杂志,2004,12(12):756-757. 被引量:13
  • 2陈敏华,严昆,杨薇,高文,戴莹,王艳滨,张晖,霍苓,邢宝才,黄信孚.343例肝恶性肿瘤射频消融疗效及并发症[J].北京大学学报(医学版),2005,37(3):292-296. 被引量:64
  • 3Lencioni RA,Allgaier HP,Cioni D,et al.Small hepatocellularcarcinoma in cirrhosis:randomized comparison of radio-fre-quency thermal ablation versus percutaneous ethanol injec-tion[J].Radiology,2003,228(1):235-240.
  • 4Rossi S,Di Stasi M,Buscarini E.Percutaneous RF interstitialthermal ablation in the treatment of hepatic cancer[J].AJRAm J Roentgenol,1996,167(3):759-768.
  • 5Tateishi R,Shiina S,Teratani T,et al.Percutaneous radio-frequency ablation for hepatocellular carcinoma—an analysisof 1000 cases[J].Cancer,2005,103(6):1201-1209.
  • 6Peng ZW,Zhang YJ,Chen MS,et al.Radiofrequency abla-tion as first-line treatment for small solitary hepatocellularcarcinoma:long-term results[J].Eur J Surg Oncol,2010,36(11):1054-1060.
  • 7Livraghi T,Solbiati L,Meloni MF,et al.Treatment of livertumors with percutaneous radio-frequency ablation:compli-cations encountered in a multicenter study[J].Radiofre-quency,2003,226(2):441-451.
  • 8Vivarelli M,Guglielmi A,Ruzzenete A,et al.Surgical resec-tion versus percutaneous radiofrequency ablation in the treat-ment of hepatocellular carcinoma on cirrhotic liver[J].AnnSurg,2004,240(1):102-107.
  • 9Huang J,Yan L,Cheng Z,et al.A randomized trial compa-ring radiofrequency ablation and surgical resection for HCCconforming to the Milan criteria[J].Ann Surg,2010,252(6):903-912.
  • 10Chen MS,Li JQ,Zheng Y,et al.A prospective randomizedtrial comparing percutaneous local ablative therapy and partialhepatectomy for small hepatocellular carcinoma[J].AnnSurg,2006,243(3):321-328.

共引文献26

同被引文献14

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部